Onderzoeker
Veerle Boecxstaens
- Disciplines:Oncologische heelkunde
Affiliaties
- Oncologische Heelkunde (Afdeling)
Lid
Vanaf1 okt 2015 → Heden - Translationeel Onderzoek van Gastro-enterologische Aandoeningen (TARGID) (Afdeling)
Lid
Vanaf1 aug 2009 → 30 sep 2015
Projecten
1 - 1 of 1
- Modern beeld en nieuwe inzichten in middel –en lange termijn vasculaire toegangVanaf18 nov 2021 → HedenFinanciering: Eigen Middelen zoals patrimonium, inschrijvingsgelden, giften, ....
Publicaties
1 - 10 van 44
- Clinical and genetic determinants of vitamin D receptor expression in cutaneous melanoma patients.(2024)
Auteurs: Laudine Janssen, Veerle Boecxstaens, Isabelle Cleynen, Dirk Vanderschueren, Katleen Vandenberghe, Oliver Bechter, Diether Lambrechts, Maria Garmyn
Pagina's: 125 - 133 - A TCF4-dependent gene regulatory network confers resistance to immunotherapy in melanoma(2024)
Auteurs: Dennis Pedri, Ewout Landeloos, Yannick Van Herck, Katy Vandereyken, Thierry Voet, Wim Annaert, Diether Lambrechts, Veerle Boecxstaens, Joost van den Oord, Francesca Bosisio, et al.
- Variation in response rates to isolated limb perfusion in different soft-tissue tumour subtypes: an international multi-centre study(2023)
Auteurs: Veerle Boecxstaens
- Pharmacological induction of membrane lipid poly-unsaturation sensitizes melanoma to ROS inducers and overcomes acquired resistance to targeted therapy(2023)
Auteurs: Ali Talebi, Vincent de Laat, Xander Spotbeen, Jonas Dehairs, Ginevra Doglioni, David Nittner, Tania Roskams, Patrizia Agostinis, Oliver Bechter, Veerle Boecxstaens, et al.
- Melanoma cell plasticity poses diagnostic challenges: a case series(2022)
Auteurs: Yannick Van Herck, Raf Sciot, Isabelle Vanden Bempt, Veerle Boecxstaens, Maria Garmyn, Oliver Bechter
Pagina's: 428 - 439 - Metastasizing and non-metastasizing thick melanomas: clinicopathological predictors and molecular profiling.(2022)
Auteurs: Canan Guvenc, Francesca Bosisio, Veerle Boecxstaens, Maria Garmyn, Joost van den Oord
- Mapping the Immune Landscape in Metastatic Melanoma Reveals Localized Cell-Cell Interactions That Predict Immunotherapy Response(2022)
Auteurs: Yannick Van Herck, Veerle Boecxstaens, Chris Marine, Joost van den Oord, Frederik De Smet, Oliver Bechter, Francesca Bosisio
Pagina's: 3275 - 3290 - Clinical trial: a controlled trial of baclofen add-on therapy in PPI-refractory gastro-oesophageal reflux symptoms(2022)
Auteurs: Karlien Raymenants, Annelies Geeraerts, Veerle Boecxstaens, Tim Vanuytsel, Jan Tack
Pagina's: 231 - 239 - Determinants of 25-hydroxyvitamin D Status in a Cutaneous Melanoma Population(2022)
Auteurs: Julie De Smedt, Laudine Janssen, Veerle Boecxstaens, Dirk Vanderschueren, Kris Bogaerts, Katleen Vandenberghe, Oliver Bechter, Diether Lambrechts, Maria Garmyn
- Surgical management after Oxaliplatin extravasation: A case report and literature review(2022)
Auteurs: Veerle Boecxstaens